Back to top

Stifel Nicolaus Keeps Their Buy Rating on Viking Therapeutics (VKTX)

In a report released today, Annabel Samimy from Stifel Nicolaus maintained a Buy rating on Viking Therapeutics, with a price target of $95.00. Sami...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Viking Therapeutics, Inc. (VKTX)